By Sonia Elijah

Part 1 of my investigative series focused on the sudden removal of a published, peer-reviewed paper on vaccine-induced myocarditis based on US VAERS data, authored by Dr Peter McCullough, MD, MPH, and Dr Jessica Rose Ph.D., by Elsevier and Current Problems in Cardiology. Part 2 centers on my revelatory interview with Dr Pierre Kory MD, an expert critical care physician and pulmonary (lung) specialist. Dr Kory is a world pioneer in the use of ultrasound in the diagnosis and treatment of critically ill patients. He is also the co-founder and president of FLCCC (Frontline Covid-19 Critical Care Alliance).

In the interview, Dr Kory exposed the shocking acts, of what can only be described as censorship, perpetrated by well-known scientific journals, characterized by the sudden removal of peer-reviewed published papers showing statistically significant results for ivermectin as an early Covid-19 treatment and prophylaxis. He spoke about the “ludicrous” Covid vaccine mandates and the alarming ‘capture’ of these prominent scientific journals, where “only the scientific papers that get published are those that further the narrative.”

Subscribe to the Trialsitenews "Video" Channel

No spam - we promise

“We weren’t the FLCCC at the time, but in essence, we already were.”

Dr Kory candidly spoke, how in the early days of the pandemic, he was part of a group of critical care doctors, including Dr Paul Marik, Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School, who rallied together to develop treatment protocols for the “the sickest of the sick.” It was the genesis of the FLCCC. This pioneer group, with over 2000 peer-reviewed publications amongst its members, formulated what is widely known as the Math + hospital treatment protocol for Covid-19. They were the first to offer guidance on efficacious medications to treat hospitalized Covid-19 patients, incorporating the use of corticosteroids and other repurposed treatments. After the initial criticism, their protocol was later widely adopted in many countries.

Dr Kory’s testifies in front of the US Senate, twice.

Dr Kory gained worldwide attention for testifying twice in front of the US senate, first in May 2020, advocating the use of corticosteroids. Dr Kory disclosed that ivermectin was not used in their original Covid-19 treatment protocol but was being closely followed. It took another six months, when dramatic results came in from the randomized controlled trials, showing this generic anti-parasitic drug to be “highly effective at controlling the pandemic.” The results were significant enough to compel Dr Kory to testify once again in front of the US Senate, in December, advocating for its use as a lifesaving Covid-19 treatment.

In his ten-minute testimony, Dr Kory described ivermectin as a “wonder drug” attributed to “the mountains of data” that had emerged. The video footage went viral, with over a million view in the first few days. In return, for sticking his head above the parapet, this eminent ICU physician received a barrage of attacks from the mainstream media. However, it did not deter other doctors from around the world, who having heard Dr Kory’s powerful testimony, propelled them to investigate the effectiveness of ivermectin as a Covid-19 treatment, leading many to prescribe it for their patients.

“You can’t find the Science behind the government Covid policies.”

Dr Kory went on to describe how many of the government Covid policies are unscientific, by pointing out the fact that the data does not support the “monolithic vaccination policy” and the mask mandates being used everywhere. Dr Kory explained while Covid vaccines may have a role, they can’t be used as “the only thing.” He was perplexed by the “obsessive need to vaccinate everyone including the naturally immune.” He described the recent FDA approval in the vaccination for 5–11-year-olds as “ludicrous” by highlighting the fact that there is no long term safety data, and going on to state, “we now have papers showing the rate of hospitalization from myocarditis in young people exceeds the rate of hospitalization from Covid.”

“There is a major opposition to ivermectin and the first time that opposition raised its ugly head was with our paper.”

In response to my question about the retraction of his peer-reviewed comprehensive paper on ivermectin by Frontiers in Pharmacology, Dr Kory stated, “my experience is not unique, it’s happened to many other authors.”

His ground-breaking comprehensive review concluded that “ivermectin, based on the risk- benefit profile and overwhelming reproduceable efficacy, should be deployed immediately in the prevention and treatment of Covid-19.” Dr Kory went on to explain how his paper “was peer-reviewed by three senior governmental scientists and an expert clinician; it went through three rounds of peer-review and was accepted for publication, however, the publication date kept on getting pushed back. Suddenly, we were told by the lead editor of all the Frontier journals that they were not going to publish our paper but retract it.”

When I asked what reason they gave, Dr Kory responded, “they called in an anonymous peer-reviewer, who felt our conclusions were unsupported.”

Censorship by the scientific journals.

Dr Kory went on to list the disturbing number of other papers that have either been retracted after publication; accepted for publication but then later rejected or outright rejected from the beginning.

Dr Tess Lawrie MD, Ph.D., a world expert in systematic reviews and meta-analysis, conducted a peer-reviewed systematic meta-analysis of ivermectin, which was accepted for publishing by The Lancet Respiratory Medicine journal but was later rejected, based on the editor not believing the evidence was strong enough.

Dr Puya Dehgani-Mobaraki MD, a head and neck surgeon, wrote a masterful science review on the mechanisms of action of ivermectin in Covid-19. It was published in one of the Nature journals (had over 500,000 views) but then was suddenly retracted, against the objections of the peer-reviewers.

Dr Eli Schwartz MD, from Sheba Medical Centre in Israel, did a placebo double blinded randomized controlled trial on ivermectin showing massive reductions in the time to viral clearance, proving it to be a powerful anti-viral drug. It was rejected outright by all the high-impact journals.

Dr. Waheed Shouman, from Zagazig University in Egypt, did a major prophylactic trial on ivermectin. TrialSite covered this trial in an article in August 2020. Shouman had to stop the trial early because the difference between the control and the treatment group was so vast that it would have been unethical to carry on. No high impact journal wanted to publish his findings.

“The enemy isn’t ivermectin..it’s the cheap repurposed drugs that would compete in a marketplace with profitable patented drugs.”

Dr Kory revealed that in 2020 the journals and the agencies, “conspired to kill hydroxychloroquine” (an anti-malaria drug repurposed to treat Covid-19) and in 2021, “they went after ivermectin.”

However, the war on repurposed drugs did not end there. Dr Kory spoke about another drug, Proxalutamide (an androgen suppressant) and the fact that his colleague, Dr Flávio Adsuara Cadegiani from Brazil, conducted a large placebo double blinded, randomized controlled trial showing massive benefits to Covid-19 mortality and hospitalization. His paper was submitted to the New England Journal of Medicine and passed peer-review, soon after a letter was received by the authors stating that the journal would not be publishing it.

I found an article published in March 2021, relating to Dr Cadegiani’s successful trial in the European Pharmaceutical Review, the headline ran ‘Proxalutamide reduces Covid-19 mortality risk by 92 percent.’

What is so shocking about these cheap repurposed drugs showing strong clinical benefits in treating Covid-19, is imagining just how many lives could have been saved over the past 20 months if the scientific journals chose not to engage in censorship.